Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

IgG3 antibody

Reactivity: Human WB Host: Rabbit Monoclonal unconjugated
Catalog No. ABIN7267839
  • Target See all IgG3 Antibodies
    IgG3
    Reactivity
    Human
    Host
    • 4
    • 2
    Rabbit
    Clonality
    • 5
    • 1
    Monoclonal
    Conjugate
    • 3
    • 1
    • 1
    • 1
    This IgG3 antibody is un-conjugated
    Application
    • 4
    • 2
    Western Blotting (WB)
    Purpose
    Human IgG3 Rabbit mAb
    Cross-Reactivity
    Human, Mouse, Rat
    Characteristics
    Monoclonal Antibodies
    Purification
    Affinity purification
    Immunogen
    A synthesized peptide derived from human Human IgG3
    Isotype
    IgG
    Top Product
    Discover our top product IgG3 Primary Antibody
  • Application Notes
    WB,1:500 - 1:2000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    PBS with 0.02 % sodium azide,0.05 % BSA,50 % glycerol, pH 7.3.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C
    Storage Comment
    Store at -20°C. Avoid freeze / thaw cycles.
  • Target
    IgG3
    Alternative Name
    IGHG3 (IgG3 Products)
    Synonyms
    IgG3 antibody, Immunoglobulin heavy constant gamma 3 antibody, immunoglobulin heavy constant gamma 3 (G3m marker) antibody, Ighg3 antibody, IGHG3 antibody
    Target Type
    Antibody
    Background
    Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens. The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen.,IgG3,Immunology & Inflammation,IGHG3
    Molecular Weight
    kDa
    Gene ID
    3502
    UniProt
    P01860
You are here: